111 related articles for article (PubMed ID: 5028220)
1. The use of diazoxide inhibition of insulin secretion as a tool to investigate insulin stimulation by other agents.
Gulbenkian A; Ornstein L; Tabachnick II
Horm Metab Res; 1972 Mar; 4(2):57-8. PubMed ID: 5028220
[No Abstract] [Full Text] [Related]
2. Hyperresponsiveness to tolbutamide of dogs pretreated with diazoxide.
Anderson JH; Byrd GW; Blackard WG
Metabolism; 1971 Nov; 20(11):1023-30. PubMed ID: 4329940
[No Abstract] [Full Text] [Related]
3. Insulin secretion studied in the perfused rat pancreas. I. Effect of tolbutamide, leucine and arginine; their interaction with diazoxide, and relation to glucose.
Basabe JC; Lopez NL; Viktora JK; Wolff FW
Diabetes; 1971 Jul; 20(7):449-56. PubMed ID: 5556282
[No Abstract] [Full Text] [Related]
4. The morphological substrate of the inhibition of insulin secretion by diazoxide.
Creutzfeldt W; Creutzfeldt C; Frerichs H; Perings E; Sicklinger K
Horm Metab Res; 1969 Mar; 1(2):53-64. PubMed ID: 4334867
[No Abstract] [Full Text] [Related]
5. Analysis of the stimulating action of tolbutamide on the secretion of insulin using mannoheptulose and diazoxide.
Loubatières-Mariani MM; Loubatières AL; Chapal J
Diabetologia; 1973 Apr; 9(2):152-7. PubMed ID: 4716116
[No Abstract] [Full Text] [Related]
6. [Pharmacological studies of a new highly effective blood sugar decreasing sulfonamide, glibenclamide (HB 419)].
Loubatières A; Mariani MM; Ribes G; de Malbosc H; Alric R; Chapal J
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1354-63. PubMed ID: 4899083
[No Abstract] [Full Text] [Related]
7. Inhibition of insulin release by diphenylhydantoin and diazoxide in a patient with benign insulinoma.
Cohen MS; Bower RH; Fidler SM; Johnsonbaugh RE; Sode J
Lancet; 1973 Jan; 1(7793):40-1. PubMed ID: 4118560
[No Abstract] [Full Text] [Related]
8. Insulin secretory blockade by benzothiadiazines and catecholamines: reversal by sulfonylureas.
Seltzer HS; Crout JR
Ann N Y Acad Sci; 1968 Apr; 150(2):309-21. PubMed ID: 4875710
[No Abstract] [Full Text] [Related]
9. The action of diazoxide on insulin secretion, medullo-adrenal secretion, and the liberation of catecholamines.
Loubatières A; Mariani MM; Alric R
Ann N Y Acad Sci; 1968 Apr; 150(2):226-41. PubMed ID: 4875709
[No Abstract] [Full Text] [Related]
10. [Modification of insulin-secretion, induced by glucose, of the isolation-perfused rat pancreas using tolbutamide, glucosamine, diazoxide, glucagon and endogenous insulin].
Bierwolf B; Blech W
Acta Biol Med Ger; 1976; 35(5):583-95. PubMed ID: 983609
[TBL] [Abstract][Full Text] [Related]
11. Tolbutamide and diazoxide modulate phospholipase C-linked Ca(2+) signaling and insulin secretion in beta-cells.
Schöfl C; Börger J; Mader T; Waring M; von zur Mühlen A; Brabant G
Am J Physiol Endocrinol Metab; 2000 Apr; 278(4):E639-47. PubMed ID: 10751197
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of insulin release in the dog by a nonmetabollizable amino acid. Comparison with leucine and arginine.
Fajans SS; Quibrera R; Pek S; Floyd JC; Christensen HN; Conn JW
J Clin Endocrinol Metab; 1971 Jul; 33(1):35-41. PubMed ID: 4934141
[No Abstract] [Full Text] [Related]
13. [Recent pharmacologic aspects of sulfamides modifying insulin secretion (hypoglycemic and hyperglycemic sulfamides)].
Loubatiéres A; Mariani MM
Actual Physiol Pathol (Paris); 1973; 4():237-66. PubMed ID: 4219256
[No Abstract] [Full Text] [Related]
14. Improvement in insulin secretion in diabetes after diazoxide.
Greenwood RH; Mahler RF; Hales CN
Lancet; 1976 Feb; 1(7957):444-7. PubMed ID: 55717
[TBL] [Abstract][Full Text] [Related]
15. [Inhibition of the metabolic and circulatory (cardiovascular) effects of diazoxide through alpha--and beta-receptor blockade].
Börner E; Biro G; Kettl H; Weinges KF
Horm Metab Res; 1969 Nov; 1(6):296-300. PubMed ID: 4401003
[No Abstract] [Full Text] [Related]
16. [The action of sulfonylureas on the insulin secretion of the perfused rat pancreas].
Mariani MM
Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():256-70. PubMed ID: 5371307
[No Abstract] [Full Text] [Related]
17. [Oral antidiabetics. Dose, plasma concentration and effect].
Ariëns EJ
Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():143-76. PubMed ID: 4392071
[No Abstract] [Full Text] [Related]
18. [Sulfonamides modifying insulin secretion and the development of the islands of Langerhans. Actions and antagonisms of actions. Some experimental studies of their clinical applications].
Loubatières A; Mariani MM; Alric R
Bull Acad Natl Med; 1967 Dec; 151(33):683-94. PubMed ID: 4866937
[No Abstract] [Full Text] [Related]
19. [Insulin liberation from the pancreas by sulfonylurea].
Pfaff W; Schöne HH
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1445-8. PubMed ID: 4899084
[No Abstract] [Full Text] [Related]
20. Interaction of various stimulators and inhibitors on insulin secretion in vitro.
Voyles N; Gutman RA; Selawry H; Fink G; Penhos JC; Recant L
Horm Res; 1973; 4(2):65-73. PubMed ID: 4355994
[No Abstract] [Full Text] [Related]
[Next] [New Search]
